Archive for the ‘
Pharmaceutical operations ’ Category
Friday, June 18th, 2010
The top issue vexing pharmaceutical executives is the changing commercial business model, according to "2010 Pharma Insights," a new report from Cegedim Dendrite. The pharma CRM and data solutions company conducted an online survey of 211 pharmaceutical executives in North and South America. Thirty-five percent of surveyed executives cited the ...
Posted in
DTC advertising, Economy, Pharmaceutical operations, Sales & Marketing, Sales force effectiveness, Social media in pharma, Technology |
No Comments »
Tuesday, January 19th, 2010
A 9-year-old boy obsesses over his mayoral approval rating within the online world of Sim City 2000. A 13-year-old girl misses dinner to attend a board meeting as her World of Warcraft compatriots debate the merits of a guild merger. Speaking today at a panel discussion hosted by ProtonMedia and ...
Posted in
Economy, Pharma Business, Pharmaceutical operations, Professional education, Sales force effectiveness, Technology, e-Marketing |
3 Comments »
Wednesday, January 13th, 2010
As J.P. Morgan’s 28th Annual Healthcare Conference in San Francisco winds down, Kevin Butler of Heritage Partners International checks in with one final report.
Although there is guarded optimism all around, Mr. Butler believes that we can expect any shock to the system to cause major trauma. “Perhaps if ee get ...
Posted in
Pharma Business, Pharmaceutical operations |
1 Comment »
Tuesday, January 12th, 2010
Kevin Butler of Heritage Partners International has reported in with his Tuesday afternoon update from J.P. Morgan’s 28th Annual Healthcare Conference in San Francisco.
In his previous update, Mr. Butler reported good spirits among the attendees. However, there seems to be an East Coast/West Coast divide.
“The West Coast people seem much ...
Posted in
Pharma Business, Pharmaceutical operations |
1 Comment »
Tuesday, January 12th, 2010
Frequent Med Ad News contributor Kevin Butler of Heritage Partners International is in attendance at J.P. Morgan’s 28th Annual Healthcare Conference in San Francisco. Mr. Butler will be checking in routinely with updates from the event, which brings together industry leaders and technology and service providers.
Upon arriving yesterday, January 11, ...
Posted in
Pharma Business, Pharmaceutical operations |
1 Comment »
Monday, December 21st, 2009
Healthcare reform has taken a major step forward as the Democratic caucus voted to curtail debate on the bill. The final vote on the Senate’s version of healthcare reform could come by Christmas, at which point the Senate must then draft a compromise with the House, which approved its own ...
Posted in
Legal actions, Pharma Business, Pharmaceutical operations, Sales & Marketing |
1 Comment »
Wednesday, December 2nd, 2009
Healthcare reform and changing business models could have profound tax implications for the pharmaceutical industry.
Yesterday, PricewaterhouseCoopers announced a new report called “Pharma 2020: Taxing times ahead - Which path will you take?”, which looks at the forces that are driving up the effective tax rate for pharmaceutical and life sciences ...
Posted in
Economy, Legal actions, Pharma Business, Pharmaceutical operations |
1 Comment »
Friday, September 25th, 2009
The remaining hours of Med Ad News' PharmaMed conference teased out strategic solutions the industry should hearken to for the sake of brand identity, positioning, and strategy. Echoing earlier sentiments about a challenging economic climate and carping at common regulatory frustrations, speakers throughout Day No. 2's afternoon sessions focused on ...
Posted in
Economy, Patient education, Pharmaceutical operations, Professional education, Sales force effectiveness, Technology |
1 Comment »
Thursday, July 30th, 2009
According to a new PricewaterhouseCoopers LLP report, growth in personalized medicine is driving alliances between diagnostics and the pharmaceutical industry. PwC expects the annual number of partnerships between pharmaceutical and diagnostic companies to increase during the next five years. One key factor expected to drive future partnerships is increased pressure ...
Posted in
Pharmaceutical operations, Uncategorized |
2 Comments »
Thursday, July 2nd, 2009
The convergence of a number of factors is set to continue to drive growth and investment in the oncology market going forward. According to Andrew Jones, senior industry analyst, Pharmaceutical Sector Team, Ernst & Young (ey.com), these factors include high unmet need, favorable demographics, defensible technology, and specialty economics. Despite ...
Posted in
Pharmaceutical operations, cancer, pharmaceutical R&D |
No Comments »
|
|
